Thread: Neurosearch AS said it has initiated phase I clinical studies of the drug candidate A
View Single Post
Old 12-18-2007, 11:04 AM
Stitcher's Avatar
Stitcher Stitcher is offline
Magnate
  
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Stitcher Stitcher is offline
Magnate
Stitcher's Avatar
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Default Neurosearch AS said it has initiated phase I clinical studies of the drug candidate A
AFX News Limited

Neurosearch starts phase I study on drug as new Parkinson's disease treatment

12.18.07, 4:55 AM ET
http://www.forbes.com/afxnewslimited...fx4451163.html

COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Neurosearch AS said it has initiated phase I clinical studies of the drug candidate ACR343 with a view to develop it as a new treatment for Parkinson's disease.

'This achievement further highlights the very satisfactory...development seen in the pipeline programmes we took over with the acquisition of Carlsson Research (now Neurosearch Sweden) in October 2006,' Neurosearch chief executive Flemming Pedersen said.

As an effect of the study initiation, Neurosearch will make a 75 mln skr milestone payment to the former shareholders of Carlsson Research AB, the company said.

Neurosearch reiterated its previous financial guidance for 2007 of a 230-250 mln dkr loss before recognition of associates and other equity interests.

gustav.sandstrom@thomson.com
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall

I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller
Stitcher is offline   Reply With QuoteReply With Quote